Literature DB >> 19126048

Herpes simplex virus: a histopathologic study of the depth of herpetic wounds.

Asha R Patel1, Paolo Romanelli, Brenda Roberts, Robert S Kirsner.   

Abstract

BACKGROUND: Herpes is a prevalent, infectious disease that can occur anywhere on the body; it is found primarily on the face and genitalia. Herpes simplex virus type 1 (HSV-1) and herpes simplex virus type 2 (HSV-2) are the DNA viruses that cause human herpes. Clinically, HSV-1 and HSV-2 infections produce lesions generally located on the mucocutaneous junctions of the face and genitalia. At times, vesicular lesions may ulcerate, leaving recalcitrant wounds that are challenging to treat. Until now, the basis of treatment has been related to the eradication of the viral infection. Little attention has focused on the consequence of the viral infection and the resulting wounds, specifically whether this represents an epidermal or dermal injury.
METHODS: Using 10 herpetic lesions from different individuals, we studied the depth of the injury via routine hematoxylin and eosin stains, as well as periodic acid-Schiff (PAS) and type IV collagen stains, which demonstrate the presence of the basement membrane.
RESULTS: In all cases, we found an inflammatory infiltrate in the dermis and selective disruption of the basement membrane.
CONCLUSION: This suggests that herpetic lesions involve the dermis and are best classified as partial-thickness wounds.

Entities:  

Mesh:

Year:  2009        PMID: 19126048     DOI: 10.1111/j.1365-4632.2009.03788.x

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  6 in total

Review 1.  Novel composite efficacy measure to demonstrate the rationale and efficacy of combination antiviral-anti-inflammatory treatment for recurrent herpes simplex labialis.

Authors:  Christopher M Hull; Myron J Levin; Stephen K Tyring; Spotswood L Spruance
Journal:  Antimicrob Agents Chemother       Date:  2013-12-16       Impact factor: 5.191

2.  Different modes of herpes simplex virus type 1 spread in brain and skin tissues.

Authors:  Yael Tsalenchuck; Tomer Tzur; Israel Steiner; Amos Panet
Journal:  J Neurovirol       Date:  2014-01-10       Impact factor: 2.643

3.  Stepwise release of biologically active HMGB1 during HSV-2 infection.

Authors:  Chloé Borde; Stéphanie Barnay-Verdier; Claire Gaillard; Hakim Hocini; Vincent Maréchal; Joël Gozlan
Journal:  PLoS One       Date:  2011-01-19       Impact factor: 3.240

4.  Herpes simplex virus type 1 penetrates the basement membrane in human nasal respiratory mucosa.

Authors:  Sarah Glorieux; Claus Bachert; Herman W Favoreel; Annelies P Vandekerckhove; Lennert Steukers; Anamaria Rekecki; Wim Van den Broeck; Joline Goossens; Siska Croubels; Reginald F Clayton; Hans J Nauwynck
Journal:  PLoS One       Date:  2011-07-15       Impact factor: 3.240

Review 5.  Improving the Care and Treatment of Monkeypox Patients in Low-Resource Settings: Applying Evidence from Contemporary Biomedical and Smallpox Biodefense Research.

Authors:  Mary G Reynolds; Andrea M McCollum; Beatrice Nguete; Robert Shongo Lushima; Brett W Petersen
Journal:  Viruses       Date:  2017-12-12       Impact factor: 5.048

Review 6.  Monkeypox: A Comprehensive Review of Transmission, Pathogenesis, and Manifestation.

Authors:  Jasndeep Kaler; Azhar Hussain; Gina Flores; Shehreen Kheiri; Dara Desrosiers
Journal:  Cureus       Date:  2022-07-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.